Standout Papers

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid ... 2001 2026 2009 2017 3.7k
  1. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia (2001)
    Brian Druker, Moshe Talpaz et al. New England Journal of Medicine
  2. Clinical Pharmacokinetics of Imatinib (2005)
    Bin Peng, Peter Lloyd et al. Clinical Pharmacokinetics
  3. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial (2008)
    Craig S. Anderson, Yining Huang et al. The Lancet Neurology

Immediate Impact

4 by Nobel laureates 16 from Science/Nature 151 standout
Sub-graph 1 of 16

Citing Papers

Small molecules, big impact: 20 years of targeted therapy in oncology
2020 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
15 intermediate papers

Works of Bin Peng being referenced

Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients
2004
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout

Author Peers

Author Last Decade Papers Cites
Bin Peng 1602 1757 1845 3819 2613 214 9.9k
Christine Mannhalter 911 320 802 4644 2059 338 10.8k
Keith R. McCrae 533 318 939 3579 1559 248 10.5k
Takao Koike 1075 556 772 3211 1038 326 12.1k
Pierre Ronco 914 352 3259 1867 1838 345 14.6k
Sergio Amadori 704 514 1049 9706 3635 359 15.2k
Carlos E. Bueso‐Ramos 461 415 752 5804 4157 383 14.1k
Stanley Cohen 918 532 521 4591 2301 212 17.9k
Javid J. Moslehi 948 502 2083 1121 1045 206 15.2k
Tomoki Naoe 472 644 563 7781 2673 350 15.5k
Arthur Kavanaugh 643 299 332 3441 1499 193 11.1k

All Works

Loading papers...

Rankless by CCL
2026